Luteinizing hormone-releasing hormone agonist triptorelin and antagonist Cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers

Gynecologic Oncology

Volumn 78, Issue 2, 2000, Pages 194-202

  Gründker, Carsten ^a   Völker, Peter ^a   Schulz, Klaus Dieter ^b   Emons, Günter ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; MESSENGER RNA; TRIPTORELIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER HORMONE THERAPY; ENDOMETRIUM CANCER; GENE EXPRESSION; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; ONCOGENE C FOS; OVARY CANCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033842808     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.5863     Document Type: Article

References (43)

1. The use of luteinizing hormone-releasing hormone agonists and antagonists in gynecological cancers
2. Growth-inhibitory actions of analogues of luteinizing hormone releasing hormone on tumor cells
3. Presence of gonadotropin-releasing hormone and its messenger ribunucleic acid in human ovarian epithelial carcinoma
4. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists
5. Expression of luteinizing hormone-releasing hormone and its mRNA in human endometrial cancer cell lines
6. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma
7. Gonadotropin releasing hormone binding sites in human epithelial ovarian carcinomata
8. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium
9. Characterization of binding sites for GnRH-agonist (buserelin) in human breast cancer biopsies and their distribution in relation to tumor parameters
10. Presence and characteristics of receptors for [D-Trp6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer
11. 6]-luteinizing-hormone-releasing hormone, somatostatin, epidermal growth factor and sex steroids in 500 biopsy samples of human breast cancer
12. High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines
13. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines
14. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone
15. The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary
16. Expression and signal transduction pathways of gonadotropin-releasing hormone receptors
17. Luteinizing hormone-releasing hormone agonist triptorelin antagonizes signal transduction and mitogenic activity of epidermal growth factor in human ovarian and endometrial cancer cell lines
18. Establishment of a new endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors
19. Establishment of a cell line of human endometrial adenocarcinoma in vitro
20. Cell lines derived from human ovarian carcinomas: Growth stimulation by gonadotropic and steroid hormones
21. Absence of HeLa cell contamination in 169 cell lines derived from human tumors
22. A human cell line from a pleural effusion derived from breast carcinoma
23. Guanine nucleotide modulations of high affinity gonadotropin-releasing hormone receptors in rat mammary tumors
24. Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell lines
25. Gonadotropin-releasing hormone stimulates phospholipase C but not protein phosphorylation/dephosphorylation in plasma membrane from human epithelial ovarian cancer
26. Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145
27. Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin like growth factors
28. Coupling of gonadotropin releasing hormone receptor to Gi protein in human reproductive tract tumors
29. Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling
30. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor
31. 6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma
32. Luteinizing hormone-releasing hormone agonists interfere with mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells
33. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: Evidence for an autocrine-inhibitory LHRH loop
34. Expression of mRNA for luteinizing hormone-releasing hormone receptors and epidermal growth factor recptors in human cancer cell lines
35. Decrease in the level and mRNA expression of LHRH and EGF receptors after treatment with LHRH antagonist cetrorelix in DU-145 prostate tumor xenografts in nude mice
36. Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs
37. Antitumor effect of GnRH agonist in epithelial ovarian cancer
38. Mutations of the conserved DRS motif in the second intracellular loop of the gonadotropin-releasing hormone receptor affect expression, activation, and internalization
39. The functional microdomain in transmembrane helices 2 and 7 regulates expression, activation, and coupling pathways of the gonadotropin-releasing hormone receptor
40. Tissue-specific pattern of variant transcripts of the human gonadotropin-releasing hormone receptor gene
41. Multiple mechanisms of receptor-G protein signaling specificity